Matthew Venezia
Stock Analyst at Alliance Global Partners
(3.50)
# 2,258
Out of 4,534 analysts
10
Total ratings
36.4%
Success rate
25.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Venezia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTHI NeOnc Technologies Holdings | Initiated Coverage: Buy | $13 | $3.27 | +297.55% | 1 | May 19, 2026 | |
| CAPR Capricor Therapeutics | Reiterated: Buy | $51 | $19.50 | +161.54% | 6 | May 14, 2026 | |
| PLUR Pluri | Initiated Coverage: Buy | $12 | $1.82 | n/a | 1 | Jun 2, 2025 | |
| CBUS Cibus | Reiterated: Buy | $24 | $1.76 | n/a | 2 | May 9, 2025 |
NeOnc Technologies Holdings
May 19, 2026
Initiated Coverage: Buy
Price Target: $13
Current: $3.27
Upside: +297.55%
Capricor Therapeutics
May 14, 2026
Reiterated: Buy
Price Target: $51
Current: $19.50
Upside: +161.54%
Pluri
Jun 2, 2025
Initiated Coverage: Buy
Price Target: $12
Current: $1.82
Upside: n/a
Cibus
May 9, 2025
Reiterated: Buy
Price Target: $24
Current: $1.76
Upside: n/a